Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2005
10/26/2005EP1289981A4 Novel electro-optic chromophore bridge compounds and donor-bridge compounds for polymeric thin film waveguides
10/26/2005EP1250474B1 Tellurium-containing nanocrystalline materials
10/26/2005CN1688644A Antistatic agents and polymer compositions derived therefrom
10/26/2005CN1688593A Bis-chelating ligand and use thereof in carbonylation processes
10/26/2005CN1688592A Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation
10/26/2005CN1688541A Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
10/26/2005CN1688531A Process for preparing aldehyde compounds
10/26/2005CN1688298A Composition, synthesis and therapeutic applications of polyamines
10/26/2005CN1687088A N-substituted benzothiazolyl-1-substituted phenyl-0, 0-dialkyl-alpha-amino phosphonate ester derivatives preparation and application
10/26/2005CN1687087A Method for preparing Rosuvastain and its intermediate
10/26/2005CN1687086A Substituted phenoxy-acetoxy-aromatic heterocyclic radical-alkyl ester phisphinic acid possessing bactericidal and herbicidal activity, and preparation
10/26/2005CN1687085A Ion liquid in phosphine group amino acid
10/26/2005CN1687084A Technique for producing soya bean lecithin
10/26/2005CN1687083A Compound containing vanadium for treating diabetes and preparation method thereof
10/26/2005CN1224625C Phosphorus compound
10/26/2005CN1224612C Acetylenic sulfonamide thiol TACE inhibitors
10/26/2005CN1224598C Naphthalene derivatives
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/25/2005US6958409 Process for reduced crude sediment in metal salts of hydrocarbyl dithiophosphoric acid
10/25/2005US6958345 syn-N1-(2-hydroxymethylcyclopropylidenemethyl)-cytosine for example; treating HIV, herpes viruses, Epstein-Barr virus (EBV), hepatitis B virus
10/25/2005US6958307 Monomolecular layer of organic phosphorous-containing groups bonded to a mineral oxide via an oxygen atom of the oxide to a phosphorus atom; free of phosphate, phosphonate and phosphinate phases of the mineral element; chemical stability
10/25/2005CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
10/25/2005CA2120782C Thioxanthenone antitumor agents
10/20/2005WO2005097919A1 Adhesion promoting compound
10/20/2005WO2005097814A2 Composition and method for inhibiting platelet aggregation
10/20/2005WO2005097812A1 Phosphonium salts derivatives and their use as solubility controlling auxiliaries
10/20/2005WO2005097811A1 Phosphines, transition metal complexes containing the same as the ligand, and process for production of optically active carboxylic acids
10/20/2005WO2005097810A1 Alkoxylated phosphite ester and process therefor
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005082914A3 Modulators of lysophosphatidic acid (lpa) signaling
10/20/2005WO2005073214A3 Novel inhibitors of chymase
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005019231A8 Phosphazene compound, photosensitive resin composition and use thereof
10/20/2005US20050234270 Method for producing c13-alcohol mixtures
10/20/2005US20050234257 Facile synthesis of symmetric esters of alkylenebisphosphonic acids
10/20/2005US20050234253 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere
10/20/2005US20050234247 New effector conjugates, process for their production and their pharmaceutical use
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234145 Process for photocuring with light emitting diodes
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234023 Phosphorylated glyceryl ether aluminum salt
10/20/2005US20050234021 Amino phosphonate and amino bis-phosphonate derivatives
10/20/2005US20050234020 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
10/20/2005US20050233469 Activity-based probes for protein tyrosine phosphatases
10/20/2005US20050233428 Method of affinity purifying proteins using modified bis-arsenical fluorescein
10/20/2005US20050233124 Multilayer acrylic film with improved optical and mechanical properties
10/20/2005CA2601598A1 Phosphonium salts derivatives and their use as solubility controlling auxiliaries
10/20/2005CA2561958A1 Composition and method for inhibiting platelet aggregation
10/20/2005CA2561741A1 Processes and reagents for oligonucleotide synthesis and purification
10/19/2005EP1586598A1 Process for preparation of polymeric, phosphorus-containing compositions
10/19/2005EP1586577A1 Novel phosphite compounds and novel phosphite metal complexes
10/19/2005EP1586576A1 Process for the production of pentaerythritol diphosphonates
10/19/2005EP1585750A2 Narcistatin prodrugs
10/19/2005EP1585730A1 Carboxamide derivatives and their use as factor xa inhibitors
10/19/2005CN1684970A (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
10/19/2005CN1684769A Process for the hydroformylation of an ethylenically unsaturated compound using a bidentate diphosphine composition with a bridging group comprising sp2 hybridized carbon atoms bound to the phosphorou
10/19/2005CN1684586A Sodium glyphosate compositions and process for their preparation
10/19/2005CN1683376A Monoester phosphate containing meth-acrylate structure, its preparing method and use
10/19/2005CN1223599C Phosphbenzene compounds and there use as ligands for hydroformylation catalysts
10/19/2005CN1223598C Process for making germinal disphosphonates
10/19/2005CN1223378C Cyclodextrin containing glycopeptides antibiotic pharmaceutical compositions
10/18/2005US6956133 Process for hydroformylating an olefin
10/18/2005US6956127 Alkyl group VA metal compounds
10/18/2005US6956005 Use of tellurium in carbon-supported, noble metal-containing catalysts for liquid phase oxidation reactions
10/18/2005US6955851 Hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom
10/18/2005CA2238389C Novel geranylgeranyl-derivatives, process for the preparation thereof and related pharmaceutical compositions
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005095424A1 Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
10/13/2005WO2005095423A2 Phosphonic aminoalkylene compounds and copolymers of at least one of said compounds with at least one ethylenically-unsaturated comonomer, and use of such copolymers
10/13/2005WO2005094897A2 Pegylated ion channel modulating compounds
10/13/2005WO2005063371A3 Use of structured water-soluble polymers obtained by controlled radical polymerization as a dispersant and agent for assisting in the grinding of mineral materials
10/13/2005WO2004113277A3 Methods and compositions for treating amyloid-related diseases
10/13/2005WO2004094441A3 Piperazine containing phosphonic acid compounds as inhibitors of serine proteases
10/13/2005US20050228201 By halogen exchange reaction using specific guanidinium, phosphonium or sulfonium catalysts, e.g., diethylaminobis[tris(diethylamino)phosphazenyl]-sulfonium bromide, diethylaminobis(tetramethyl-guanidino)sulfonium bromide and (N,N-dimethylimidazolidino)tetramethyl-guanidinium chloride
10/13/2005US20050228194 One-step process for making phosphonium haloalkylsulfonate antistatic agent by combining an alkyl sulfonate salt of lithium or Sodium with a tetraalkylphosphonium halogen in an aqueous medium; simple mixing of the reactants results in a precipitation of the anti-static molecule in high yield
10/13/2005US20050228190 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
10/13/2005US20050227957 Therapy for oxidation stresses; complex of drug and enzyme mimetics; lipophilic cation moiety covalently bonded to glutathione peroxidase mimetic moiety is selected from the group consisting of: benzisoselenazolones, diaryl diselenides and diaryl selenides
10/13/2005US20050227955 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
10/13/2005US20050224749 Aqueous dispersion containing pyrogenically prepared metal oxide particles and dispersants
10/13/2005DE102005007621A1 Verfahren zur Herstellung einer Verbindung, Katalysatorbestandteil zur Additionspolymerisation, Verfahren zur Herstellung eines Katalysators zur Additionspolymerisation und Verfahren zur Herstellung eines Additionspolymers A process for preparing a compound, a catalyst component for addition polymerization process for preparing a catalyst for addition polymerization and process for producing an addition polymer
10/13/2005DE102004014120A1 Polymer-bonded phosphonium-acetic acid active esters for use in the synthesis of heterocyclics and chalcones
10/13/2005DE10018969B4 Hydrolysestabile und polymerisierbare Acrylphosphonsäuremonoester Hydrolysis-stable and polymerizable acrylophosphonic acid monoesters
10/13/2005CA2561755A1 Preparation of p-chirogenic phospholanes and their use in asymmetric synthesis
10/13/2005CA2561733A1 Pegylated ion channel modulating compounds
10/12/2005EP1584668A2 Use of special vanadium compounds as driers for oxidatively drying paints
10/12/2005EP1583768A1 Risedronate sodium having a very low content of iron
10/12/2005EP1583767A1 New phosphoramide derivatives
10/12/2005EP1583766A1 Process for preparing phosphorodiamidites
10/12/2005EP1583765A2 Compositions for treating and/or preventing diseases characterized by the presence of metal ions
10/12/2005EP1583552A2 Antineoplastic ether lipid compounds
10/12/2005EP1583486A1 Stent with variable stiffness
10/12/2005EP1583458A2 Lipophilic electrophoretic probes
10/12/2005EP1242408B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005CN1681865A Curing agent for epoxide resins, use thereof and cured epoxide resin therewith
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681760A Production of dialdehydes and/or ethylenically unsaturated monoaldehydes by hydroformylation of a compound having two ethylenically unsaturated double bonds
10/12/2005CN1681508A Novel inhibitors of kinases
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 554